User contributions
From WikiPathways
(Latest | Earliest) View (newer 50) (older 50) (20 | 50 | 100 | 250 | 500)
- 12:33, 20 December 2024 Homo sapiens:SCFA and skeletal muscle substrate metabolism (Ontology Term : 'cell of skeletal muscle' added !) (top)
- 12:32, 20 December 2024 Homo sapiens:SCFA and skeletal muscle substrate metabolism (Fix truncated text)
- 12:31, 20 December 2024 Homo sapiens:SCFA and skeletal muscle substrate metabolism (Standardize case)
- 12:30, 20 December 2024 Homo sapiens:SCFA and skeletal muscle substrate metabolism (Economize layout)
- 02:20, 20 December 2024 Homo sapiens:Photodynamic therapy-induced AP-1 survival signaling (Clear cache for board dimensions) (top)
- 04:19, 13 December 2024 Homo sapiens:Albuterol and budesonide therapy for asthma (Add phosphorylation states) (top)
- 04:11, 13 December 2024 Homo sapiens:Albuterol and budesonide therapy for asthma (Ontology Term : 'drug pathway' added !)
- 04:11, 13 December 2024 Homo sapiens:Albuterol and budesonide therapy for asthma (Ontology Term : 'asthma pathway' added !)
- 04:10, 13 December 2024 Homo sapiens:Albuterol and budesonide therapy for asthma (Ontology Term : 'asthma' added !)
- 04:10, 13 December 2024 Homo sapiens:Albuterol and budesonide therapy for asthma (Ontology Term : 'bronchial smooth muscle cell' added !)
- 04:09, 13 December 2024 Homo sapiens:Albuterol and budesonide therapy for asthma (Add metabolite and phenotype identifiers)
- 03:46, 13 December 2024 Homo sapiens:Albuterol and budesonide therapy for asthma (Add Ensembl identifiers for genes)
- 02:55, 13 December 2024 Homo sapiens:Albuterol and budesonide therapy for asthma (Label cell type: airway smooth muscle cell)
- 02:49, 13 December 2024 Homo sapiens:Albuterol and budesonide therapy for asthma (Economize layout)
- 02:47, 13 December 2024 Homo sapiens:Albuterol and budesonide therapy for asthma (Add more interactions)
- 05:01, 12 December 2024 Homo sapiens:Albuterol and budesonide therapy for asthma (Add more interactions)
- 04:50, 12 December 2024 Homo sapiens:Albuterol and budesonide therapy for asthma (Add more interactions, nodes, refine arrangement)
- 04:35, 12 December 2024 Homo sapiens:Albuterol and budesonide therapy for asthma (Add interactions, economize layout)
- 03:10, 12 December 2024 Homo sapiens:Albuterol and budesonide therapy for asthma (Refine arrangement)
- 04:30, 11 December 2024 Homo sapiens:Albuterol and budesonide therapy for asthma (Add more nodes, begin arranging)
- 02:51, 11 December 2024 Homo sapiens:Albuterol and budesonide therapy for asthma (Refine PKA into labeled complexes)
- 02:35, 11 December 2024 Homo sapiens:Albuterol and budesonide therapy for asthma (Refine alignment)
- 02:14, 11 December 2024 N Homo sapiens:Albuterol and budesonide therapy for asthma (New pathway)
- 03:38, 10 December 2024 Homo sapiens:GNAQ p.R183Q drives capillary malformation (Ontology Term : 'disease pathway' added !) (top)
- 03:26, 10 December 2024 Homo sapiens:GNAQ p.R183Q drives capillary malformation (Ontology Term : 'Sturge-Weber syndrome' added !)
- 03:09, 10 December 2024 Homo sapiens:GNAQ p.R183Q drives capillary malformation (Ontology Term : 'vascular disease' added !)
- 03:02, 10 December 2024 Homo sapiens:GNAQ p.R183Q drives capillary malformation (Ontology Term : 'endothelial cell' added !)
- 02:58, 10 December 2024 Homo sapiens:GNAQ p.R183Q drives capillary malformation (Label cell type: endothelial cell)
- 02:39, 10 December 2024 Homo sapiens:GNAQ p.R183Q drives capillary malformation (Add literature reference)
- 02:38, 10 December 2024 Homo sapiens:GNAQ p.R183Q drives capillary malformation (Identify phenotype nodes)
- 02:35, 10 December 2024 Homo sapiens:GNAQ p.R183Q drives capillary malformation (Color phenotype nodes, economize layout)
- 02:07, 10 December 2024 Homo sapiens:GNAQ p.R183Q drives capillary malformation (Add identifiers for metabolite nodes)
- 23:51, 9 December 2024 Homo sapiens:GNAQ p.R183Q drives capillary malformation (Add Ensembl IDs as gene identifiers)
- 13:20, 9 December 2024 Homo sapiens:GNAQ p.R183Q drives capillary malformation (Add more nodes, interactions)
- 04:56, 9 December 2024 Homo sapiens:GNAQ p.R183Q drives capillary malformation (Add more nodes, arrange)
- 19:37, 8 December 2024 N Homo sapiens:GNAQ p.R183Q drives capillary malformation (New pathway)
- 16:36, 8 December 2024 Homo sapiens:Inhibition of GNAQ-regulated signaling in uveal melanoma (Add DrugBank ID for darovasertib) (top)
- 16:33, 8 December 2024 Homo sapiens:Inhibition of GNAQ-regulated signaling in uveal melanoma (Economize layout)
- 16:29, 8 December 2024 Homo sapiens:Inhibition of GNAQ-regulated signaling in uveal melanoma (Economize layout)
- 16:21, 8 December 2024 Homo sapiens:Inhibition of GNAQ-regulated signaling in uveal melanoma (Modified description)
- 16:20, 8 December 2024 Homo sapiens:Inhibition of GNAQ-regulated signaling in uveal melanoma (Modified title)
- 15:26, 8 December 2024 Homo sapiens:Serotonin and anxiety (Use gene symbol, identify EEF2K) (top)
- 15:17, 8 December 2024 Homo sapiens:Serotonin and anxiety (Label cell type, refine font)
- 15:13, 8 December 2024 Homo sapiens:Serotonin and anxiety (Refine layout)
- 15:11, 8 December 2024 Homo sapiens:Serotonin and anxiety (Economize layout)
- 15:09, 8 December 2024 Homo sapiens:Serotonin and anxiety (Economize layout)
- 15:02, 8 December 2024 Homo sapiens:Serotonin and anxiety (Increase font size, for readability)
- 15:00, 8 December 2024 Homo sapiens:Serotonin and anxiety (Economize layout, enrich disease nodes)
- 14:34, 8 December 2024 Homo sapiens:Serotonin HTR1 group and FOS pathway (Fix graphics discrepancy between PathVisio and Kaavio / Pvjs) (top)
- 13:18, 8 December 2024 Homo sapiens:Serotonin HTR1 group and FOS pathway (Clear cache to update board dimensions)
(Latest | Earliest) View (newer 50) (older 50) (20 | 50 | 100 | 250 | 500)
